{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:40Z","timestamp":1790380840738,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T00:00:00Z","timestamp":1495670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/leu.2017.157","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T02:40:53Z","timestamp":1495680053000},"page":"2594-2600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia"],"prefix":"10.1038","volume":"31","author":[{"given":"M","family":"Tesio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Trinquand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ballerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Hypolite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lhermitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8363-1622","authenticated-orcid":false,"given":"A","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Ifrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Asnafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,25]]},"reference":[{"key":"BFleu2017157_CR1","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.","journal-title":"N Engl J Med"},{"key":"BFleu2017157_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ni1234","volume":"6","author":"M Ciofani","year":"2005","unstructured":"Ciofani M, Zuniga-Pflucker JC . Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol 2005; 6: 881\u2013888.","journal-title":"Nat Immunol"},{"key":"BFleu2017157_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.imlet.2007.12.008","volume":"116","author":"MM Juntilla","year":"2008","unstructured":"Juntilla MM, Koretzky GA . Critical roles of the PI3K\/Akt signaling pathway in T cell development. Immunol Lett 2008; 116: 104\u2013110.","journal-title":"Immunol Lett"},{"key":"BFleu2017157_CR4","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3324\/haematol.2012.073585","volume":"98","author":"OR Bandapalli","year":"2013","unstructured":"Bandapalli OR, Zimmermann M, Kox C, Stanulla M, Schrappe M, Ludwig WD et al. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia. Haematologica 2013; 98: 928\u2013936.","journal-title":"Haematologica"},{"key":"BFleu2017157_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","volume":"114","author":"A Gutierrez","year":"2009","unstructured":"Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y et al. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood 2009; 114: 647\u2013650.","journal-title":"Blood"},{"key":"BFleu2017157_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/leu.2015.206","volume":"30","author":"S Jenkinson","year":"2015","unstructured":"Jenkinson S, Kirkwood AA, Goulden N, Vora A, Linch DC, Gale RE . Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial. Leukemia 2015; 30: 39\u201347.","journal-title":"Leukemia"},{"key":"BFleu2017157_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/leu.2009.209","volume":"24","author":"PY Jotta","year":"2010","unstructured":"Jotta PY, Ganazza MA, Silva A, Viana MB, da Silva MJ, Zambaldi LJ et al. Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia. Leukemia 2010; 24: 239\u2013242.","journal-title":"Leukemia"},{"key":"BFleu2017157_CR8","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nature05886","volume":"447","author":"RS Maser","year":"2007","unstructured":"Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007; 447: 966\u2013971.","journal-title":"Nature"},{"key":"BFleu2017157_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1636","volume":"13","author":"T Palomero","year":"2007","unstructured":"Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med 2007; 13: 1203\u20131210.","journal-title":"Nat Med"},{"key":"BFleu2017157_CR10","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1172\/JCI34616","volume":"118","author":"A Silva","year":"2008","unstructured":"Silva A, Yunes JA, Cardoso BA, Martins LR, Jotta PY, Abecasis M et al. PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability. J Clin Invest 2008; 118: 3762\u20133774.","journal-title":"J Clin Invest"},{"key":"BFleu2017157_CR11","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","volume":"31","author":"A Trinquand","year":"2013","unstructured":"Trinquand A, Tanguy-Schmidt A, Ben Abdelali R, Lambert J, Beldjord K, Lengline E et al. Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J Clin Oncol 2013; 31: 4333\u20134342.","journal-title":"J Clin Oncol"},{"key":"BFleu2017157_CR12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3324\/haematol.2011.059030","volume":"97","author":"L Zuurbier","year":"2012","unstructured":"Zuurbier L, Petricoin EF, Vuerhard MJ, Calvert V, Kooi C, Buijs-Gladdines J et al. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Haematologica 2012; 97: 1405\u20131413.","journal-title":"Haematologica"},{"key":"BFleu2017157_CR13","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood-2014-03-562751","volume":"124","author":"RD Mendes","year":"2014","unstructured":"Mendes RD, Sarmento LM, Cante-Barrett K, Zuurbier L, Buijs-Gladdines JG, Povoa V et al. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events. Blood 2014; 124: 567\u2013578.","journal-title":"Blood"},{"key":"BFleu2017157_CR14","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2008-10-186536","volume":"114","author":"M Remke","year":"2009","unstructured":"Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A et al. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood 2009; 114: 1053\u20131062.","journal-title":"Blood"},{"key":"BFleu2017157_CR15","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1038\/onc.2015.462","volume":"35","author":"M Tesio","year":"2015","unstructured":"Tesio M, Trinquand A, Macintyre E, Asnafi V . Oncogenic PTEN functions and models in T-cell malignancies. Oncogene 2015; 35: 3887\u20133896.","journal-title":"Oncogene"},{"key":"BFleu2017157_CR16","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","volume":"113","author":"V Asnafi","year":"2009","unstructured":"Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K et al. NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood 2009; 113: 3918\u20133924.","journal-title":"Blood"},{"key":"BFleu2017157_CR17","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1182\/blood-2007-04-079988","volume":"110","author":"J Bergeron","year":"2007","unstructured":"Bergeron J, Clappier E, Radford I, Buzyn A, Millien C, Soler G et al. Prognostic and oncogenic relevance of TLX1\/HOX11 expression level in T-ALLs. Blood 2007; 110: 2324\u20132330.","journal-title":"Blood"},{"key":"BFleu2017157_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R . Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 2010; 26: 589\u2013595.","journal-title":"Bioinformatics"},{"key":"BFleu2017157_CR19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010; 20: 1297\u20131303.","journal-title":"Genome Res"},{"key":"BFleu2017157_CR20","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al. The Sequence Alignment\/Map format and SAM tools. Bioinformatics 2009; 25: 2078\u20132079.","journal-title":"Bioinformatics"},{"key":"BFleu2017157_CR21","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.aab4082","volume":"349","author":"I Martincorena","year":"2015","unstructured":"Martincorena I, Campbell PJ . Somatic mutation in cancer and normal cells. Science 2015; 349: 1483\u20131489.","journal-title":"Science"},{"key":"BFleu2017157_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2014.03.027","volume":"157","author":"A Papa","year":"2014","unstructured":"Papa A, Wan L, Bonora M, Salmena L, Song MS, Hobbs RM et al. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 2014; 157: 595\u2013610.","journal-title":"Cell"},{"key":"BFleu2017157_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3324\/haematol.2015.139410","volume":"101","author":"V Gianfelici","year":"2016","unstructured":"Gianfelici V, Chiaretti S, Demeyer S, Di Giacomo F, Messina M, La Starza R et al. RNA sequencing unravels the genetics of refractory\/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications. Haematologica 2016; 101: 941\u2013950.","journal-title":"Haematologica"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2017157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2017157","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/leu2017157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:37:09Z","timestamp":1648733829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2017157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,25]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFleu2017157"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.157","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,25]]},"assertion":[{"value":"17 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}